Skip to content
Features
Resources
Ask
Pricing
Contact
Log in
Try a section
← EFSA Opinions
NDA Panel
2022
ON-7256
NSafety of the extension of use of 2’‐fucosyllactose (2’‐FL) and lacto‐‐neotetraose (LNnT) as novel foods in food supplements for infants pursuant to Regulation (EU) 2015/2283
Applicant
Glycom A/S
Substance
Lacto-N-neotetraose
Question
EFSA-Q-2021-00089
DOI
10.2903/j.efsa.2022.7257 ↗